SCHEMBL7325273

SCHEMBL7325273

COc1ccc(S(=O)(=O)Nc2cccc(C)c2C(=O)O)c(Cc2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
SLC16A3 O15427 2/20 0.47
KEAP1 Q14145 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.46
ALDH1A1 P00352 4/20 0.45
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45
RAD52 P43351 1/20 0.44
HPGD P15428 2/20 0.42
HSD17B10 Q99714 1/20 0.42
GAA P10253 1/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
METAP2 P50579 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7314686 0.89 TP53 (0.48) MEN1KMT2ASLC16A3KEAP1PTGDR2
SCHEMBL7322403 0.88 MTNR1A (0.46) MEN1KMT2ASLC16A3ALDH1A1MTNR1A
SCHEMBL7316263 0.86 MEN1 (0.67) MEN1KMT2AKEAP1ALDH1A1MTNR1A
SCHEMBL7313454 0.84 ACLY (0.51) MEN1KMT2ASLC16A3PTGDR2ALDH1A1
SCHEMBL7321851 0.82 METAP2 (0.58) MEN1KMT2ASLC16A3ALDH1A1MTNR1A
SCHEMBL7318557 0.82 ACLY (0.54) MEN1KMT2AALDH1A1MTNR1AMTNR1B
SCHEMBL7322650 0.80 METAP2 (0.58) MEN1KMT2AALDH1A1MTNR1AMTNR1B
SCHEMBL7323413 0.80 TP53 (0.45) MEN1KMT2AALDH1A1MTNR1AMTNR1B
SCHEMBL2478529 0.80 KEAP1 (0.68) MEN1KMT2ASLC16A3KEAP1ALDH1A1
SCHEMBL7317804 0.79 KMT2A (0.54) MEN1KMT2ASLC16A3PTGDR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5929097-A INHIBIT TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AMERICAN CYANAMID COMPANY (US) 1999-07-27 US disclosed